Your browser doesn't support javascript.
loading
Cardiotoxicity Associated with Immune Checkpoint Inhibitors.
Minegishi, Shintaro; Horita, Nobuyuki; Ishigami, Tomoaki; Hibi, Kiyoshi.
Afiliación
  • Minegishi S; Department of Cardiology, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.
  • Horita N; Chemotherapy Center, Yokohama City University Hospital, Yokohama 236-0004, Japan.
  • Ishigami T; Department of Cardiology, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.
  • Hibi K; Department of Cardiology, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.
Cancers (Basel) ; 15(22)2023 Nov 20.
Article en En | MEDLINE | ID: mdl-38001747
ABSTRACT
Immune checkpoint inhibitors (ICIs) have shown significant efficacy in various cancers, including non-small cell lung cancer, small cell lung cancer, melanoma, classical Hodgkin lymphoma, head and neck squamous cell carcinoma, urothelial cancer, and renal cell carcinoma [...].
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Japón